The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Head and Neck Cancer Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.
Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market.
The global Head and Neck Cancer Therapeutics market size is expected to reach US$ 1703.9 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Head and Neck Cancer Therapeutics in various end use industries. The expanding demands from the Surgery, Radiation therapy, Chemotherapy and Immunotherapy, are propelling Head and Neck Cancer Therapeutics market. PD Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microtubule Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Head and Neck Cancer Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Head and Neck Cancer Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Head and Neck Cancer Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Head and Neck Cancer Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Head and Neck Cancer Therapeutics covered in this report include Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy’s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG and BioXpress, etc.
The global Head and Neck Cancer Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy’s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
Global Head and Neck Cancer Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Head and Neck Cancer Therapeutics market, Segment by Type:
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors
Global Head and Neck Cancer Therapeutics market, by Application
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Head and Neck Cancer Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.
Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market.
The global Head and Neck Cancer Therapeutics market size is expected to reach US$ 1703.9 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Head and Neck Cancer Therapeutics in various end use industries. The expanding demands from the Surgery, Radiation therapy, Chemotherapy and Immunotherapy, are propelling Head and Neck Cancer Therapeutics market. PD Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microtubule Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Head and Neck Cancer Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Head and Neck Cancer Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Head and Neck Cancer Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Head and Neck Cancer Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Head and Neck Cancer Therapeutics covered in this report include Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy’s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG and BioXpress, etc.
The global Head and Neck Cancer Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy’s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
Global Head and Neck Cancer Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Head and Neck Cancer Therapeutics market, Segment by Type:
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors
Global Head and Neck Cancer Therapeutics market, by Application
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Head and Neck Cancer Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Head and Neck Cancer Therapeutics
1.1 Head and Neck Cancer Therapeutics Market Overview
1.1.1 Head and Neck Cancer Therapeutics Product Scope
1.1.2 Head and Neck Cancer Therapeutics Market Status and Outlook
1.2 Global Head and Neck Cancer Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Head and Neck Cancer Therapeutics Market Size by Region (2018-2029)
1.4 Global Head and Neck Cancer Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Head and Neck Cancer Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Head and Neck Cancer Therapeutics Market Size (2018-2029)
1.6.1 North America Head and Neck Cancer Therapeutics Market Size (2018-2029)
1.6.2 Europe Head and Neck Cancer Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Head and Neck Cancer Therapeutics Market Size (2018-2029)
1.6.4 Latin America Head and Neck Cancer Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Head and Neck Cancer Therapeutics Market Size (2018-2029)
2 Head and Neck Cancer Therapeutics Market by Type
2.1 Introduction
2.1.1 PD Inhibitors
2.1.2 Microtubule Inhibitors
2.1.3 EGFR Inhibitors
2.2 Global Head and Neck Cancer Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Head and Neck Cancer Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Head and Neck Cancer Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Head and Neck Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Head and Neck Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Head and Neck Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Head and Neck Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Head and Neck Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
3 Head and Neck Cancer Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Surgery
3.1.2 Radiation therapy
3.1.3 Chemotherapy
3.1.4 Immunotherapy
3.2 Global Head and Neck Cancer Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Head and Neck Cancer Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Head and Neck Cancer Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Head and Neck Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Head and Neck Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Head and Neck Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Head and Neck Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Head and Neck Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
4 Head and Neck Cancer Therapeutics Competition Analysis by Players
4.1 Global Head and Neck Cancer Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Head and Neck Cancer Therapeutics as of 2022)
4.3 Date of Key Players Enter into Head and Neck Cancer Therapeutics Market
4.4 Global Top Players Head and Neck Cancer Therapeutics Headquarters and Area Served
4.5 Key Players Head and Neck Cancer Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Head and Neck Cancer Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Head and Neck Cancer Therapeutics Products, Services and Solutions
5.1.4 Sanofi Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Profile
5.2.2 Eli Lilly Main Business
5.2.3 Eli Lilly Head and Neck Cancer Therapeutics Products, Services and Solutions
5.2.4 Eli Lilly Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Head and Neck Cancer Therapeutics Products, Services and Solutions
5.3.4 Amgen Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Actavis Recent Developments
5.4 Actavis
5.4.1 Actavis Profile
5.4.2 Actavis Main Business
5.4.3 Actavis Head and Neck Cancer Therapeutics Products, Services and Solutions
5.4.4 Actavis Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Actavis Recent Developments
5.5 Dr. Reddy’s Laboratories
5.5.1 Dr. Reddy’s Laboratories Profile
5.5.2 Dr. Reddy’s Laboratories Main Business
5.5.3 Dr. Reddy’s Laboratories Head and Neck Cancer Therapeutics Products, Services and Solutions
5.5.4 Dr. Reddy’s Laboratories Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Dr. Reddy’s Laboratories Recent Developments
5.6 Jiangsu Hengrui
5.6.1 Jiangsu Hengrui Profile
5.6.2 Jiangsu Hengrui Main Business
5.6.3 Jiangsu Hengrui Head and Neck Cancer Therapeutics Products, Services and Solutions
5.6.4 Jiangsu Hengrui Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Jiangsu Hengrui Recent Developments
5.7 Teva Pharmaceutical
5.7.1 Teva Pharmaceutical Profile
5.7.2 Teva Pharmaceutical Main Business
5.7.3 Teva Pharmaceutical Head and Neck Cancer Therapeutics Products, Services and Solutions
5.7.4 Teva Pharmaceutical Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Teva Pharmaceutical Recent Developments
5.8 DFG
5.8.1 DFG Profile
5.8.2 DFG Main Business
5.8.3 DFG Head and Neck Cancer Therapeutics Products, Services and Solutions
5.8.4 DFG Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 DFG Recent Developments
5.9 BioXpress
5.9.1 BioXpress Profile
5.9.2 BioXpress Main Business
5.9.3 BioXpress Head and Neck Cancer Therapeutics Products, Services and Solutions
5.9.4 BioXpress Head and Neck Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 BioXpress Recent Developments
6 North America
6.1 North America Head and Neck Cancer Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Head and Neck Cancer Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Head and Neck Cancer Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Head and Neck Cancer Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Head and Neck Cancer Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Head and Neck Cancer Therapeutics Market Dynamics
11.1 Head and Neck Cancer Therapeutics Industry Trends
11.2 Head and Neck Cancer Therapeutics Market Drivers
11.3 Head and Neck Cancer Therapeutics Market Challenges
11.4 Head and Neck Cancer Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
